Theratechnologies Inc
F:TQ8
Theratechnologies Inc
F:TQ8
Price:
1.92
EUR
27.15%
Market Cap:
€185.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Theratechnologies Inc
F:TQ8
|
CA |
|
C
|
Cigna Group
DUS:CGN
|
US |
|
S
|
SPAR Group Ltd
XBER:S8A
|
ZA |
|
C
|
Campbell Soup Co
XMUN:CSC
|
US |
|
H
|
Howmet Aerospace Inc
F:48Z
|
US |
|
Vertex Resource Group Ltd
F:4X8
|
CA |
|
Askoll Eva SpA
F:736
|
IT |
|
Crayon Group Holding ASA
F:30X
|
NO |
|
M
|
MS&AD Insurance Group Holdings Inc
XMUN:59M
|
JP |
|
Dialight PLC
F:3HQ
|
UK |
|
Milestone Pharmaceuticals Inc
NASDAQ:MIST
|
CA |
|
N
|
New Gold Inc
DUS:32N
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TQ8's stock price target?
Not Available
TQ8 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Theratechnologies Inc?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Theratechnologies Inc?
Projected CAGR
-2%
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 1 year is -2%.
What is the Operating Income forecast for Theratechnologies Inc?
Projected CAGR
37%
37%
The compound annual growth rate for Operating Income over the next 3 years is 37%.
